Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...

Researchers based in Germany have developed a perfusion process for the manufacture of oncolytic viruses. The team from the Max Planck Institute says that the new approach aims to improve virus titers ...

Please provide your email address to receive an email when new articles are posted on . Tissue perfusion pressure may be a new target for BP optimization in circulatory shock. TPP was significantly ...

Upstream process intensification using perfusion cell culture has become a necessity for meeting today’s demand in monoclonal antibodies (mAbs) bioprocessing. By sustaining higher viable cell ...